The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange Book upon the ...

Adam Fowles, Dirk Bernhardt and Brett Bostrom of Haynes Boone discuss preparing a revival petition for patents or ...

Quince Therapeutics (QNCX) “announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for U.S. Patent Application ...

New AirPod Pros, when? They may be months away from existence, but the documentation circulating through the U.S. patent ...

Key considerations for patent counsel when evaluating potential conflicts of interest, including identifying conflicts between current and former clients, understanding relevant authority, navigating ...

Tangem receives patent for private key backup technology, eliminating need for seed phrases in crypto wallets. Enhances security and accessibility.

From fundamental concepts to groundbreaking advancements, AI's integration into FinTech has transformed how businesses ...

GM has filed a patent application for a torsion-assisted folding vehicle seat back system, potentially making it easier to ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

Twelve years after the sale of Detroit's WNBA franchise, Women's Basketball League Inc. president and founder Ryan Reed ...

SOUTH SAN FRANCISCO, Calif. - Quince Therapeutics, Inc. (NASDAQ: QNCX), a biotech firm focusing on rare diseases with a current market capitalization of $67.76 million, has received a Notice of ...